Ortoklon Oct-3

Muromonab CD3 is an immunosuppressive drug, which literally translated into Russian means drugs that reduce immunity. In this article, we will look at orthoclone oct-3, which is produced by the pharmaceutical company Ortho-Pharmaceutical, located in the United States of America.

One of the main properties of Ortoklon Oct-3 is its use to prevent transplant rejection. The action of the drug is based on its ability to stimulate cell proliferation and inhibit the synthesis of interleukins IL-2, IL-4, IL-6, IL-8 and TNF-alpha, which interfere with the body's immune response to the suppression of immunoregulators. The drug can maintain the effect of immunosuppression after successful transplantation of donor tissue or organs. However, the drug itself has a number of side effects. One of the most serious is pulmonary edema, especially in people with fluid retention. You should also remember that before using Ortoklon Oct-3, you must read the instructions for use and consult a doctor, since the disease may have complications.

The use of Ortoklon OKT3 should be strictly under the supervision of a physician and strictly as prescribed. Before using the drug, it is necessary to check for interactions with other medications and possible side effects.

It is not recommended to use this drug for chronic heart failure and edema.

Orthoclone October three

Description of the drug: - Ortoklon OK-3 is an immunosuppressive drug (immunosuppressor) used to prevent kidney transplant failure. Produced by the American companies Ortho Therapeutics and Orthera Therapeutics.

Indications for use: - Indication is the prevention of rejection reaction in transpla

Ortoklon okt-3 is an immunosuppressive drug intended to prevent kidney rejection after transplantation. It is used in complex immunosuppressive therapy and belongs to the receptor classes of muromonoadpeptide and carboxypeptidismotide inhibitor, which are agents that suppress the body's immune response.

Orthoclonal OKT-3 is manufactured by Ortho-Pharmaceutical from the United States of America. The product is available in the form of an injection solution with a concentration of the active substance muromanoadperiptide of 1 mg/ml.

Indications for the use of the drug Orthoclone OCT - 3 are the prevention of rejection after organ transplantation. Contraindications are chronic heart failure, swelling. Special instructions include the mandatory presence of the patient in the cardiopulmonary department when administering the drug.

Side effects may include pulmonary edema in patients with symptoms of fluid retention. Interaction with other drugs has not been described. An overdose is impossible, but it is important to remember that the drug should be administered under the supervision of specialists.

One of the main advantages of Ortoklon OKT-3 is its effectiveness in preventing rejection and protecting transplanted tissue. However, like any drug, it has contraindications and can cause side effects, so you must strictly follow the dosage and doctor's recommendations.